Samsung Epis Holdings

Update in progress

0126Z0.KS (KSE)

Company RatingNeutral
SectorHealthcare
IndustryBiotechnology

Samsung Epis Holdings Co., Ltd. is a biotechnology company focused on developing and managing a portfolio of biopharmaceutical products. It coordinates research, development, and commercialization activities for its products and partners. The company was founded in 2025 and is headquartered in Incheon, South Korea.

Company score

Sentiment: 0.23; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.14; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.09; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.06; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.14; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive